SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zenotech Laboratories inform about board meeting

23 Apr 2026 Evaluate

Zenotech Laboratories has informed that the meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, April 29, 2026, to consider and approve Audited Standalone Financial Results of the Company for the quarter and financial year ended March 31, 2026. Further to its communication dated March 26, 2026, the Trading Window has been closed from April 01, 2026 and will remain closed until May 01, 2026, after 48 hours of the declaration of financial results.

The above information is a part of company’s filings submitted to BSE.

Zenotech Laboratorie Share Price

45.50 -1.40 (-2.99%)
24-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1619.95
Dr. Reddys Lab 1315.85
Cipla 1294.75
Zydus Lifesciences 927.15
Lupin 2296.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×